Connection

Syed Hasan to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Antiviral Agents.
Syed Hasan
Connection Strength
0.427
Antiviral Agents
  1. The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229.
    View in: PubMed
    Score: 0.088
  2. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021 Aug; 77(8):1089-1094.
    View in: PubMed
    Score: 0.086
  3. Interferon-based therapies in COVID-19. Int Immunopharmacol. 2021 Apr; 93:107415.
    View in: PubMed
    Score: 0.085
  4. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021 04; 93(4):1860-1861.
    View in: PubMed
    Score: 0.084
  5. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.